Table 1 Patient Characteristics
Descriptive Statistics | Count | % | |
|---|---|---|---|
Age | ≤60 | 101 | 46.3% |
| Â | >60 | 117 | 53.7% |
Gender | Male | 147 | 67.4% |
| Â | Female | 71 | 32.6% |
| Â | 60-70 | 66 | 30.3% |
Karnofsky PS | 80 | 84 | 38.5% |
| Â | 90-100 | 68 | 31.2% |
| Â | 1 | 11 | 5.0% |
Histological Grade | 2 | 129 | 59.2% |
| Â | 3 | 78 | 35.8% |
Lymph Node Metastasis | No | 45 | 20.6% |
| Â | Yes | 173 | 79.4% |
Liver Metastasis | No | 112 | 51.4% |
| Â | Yes | 106 | 48.6% |
Lung Metastasis | No | 201 | 92.2% |
| Â | Yes | 17 | 7.8% |
Ovary Metastasis | No | 197 | 90.4% |
| Â | Yes | 21 | 9.6% |
Bone Metastasis | No | 211 | 96.8% |
| Â | Yes | 7 | 3.2% |
Peritoneal dissemination | No | 122 | 56.0% |
| Â | Yes | 96 | 44.0% |
Albumin (normal range >3.4 g/dl) | Normal | 137 | 62.8% |
| Â | Low | 81 | 37.2% |
CRP (normal range ≤5 mg/dl) | Normal | 132 | 60.6% |
| Â | High | 86 | 39.4% |
HP | No | 142 | 65.1% |
| Â | Yes | 76 | 34.9% |
CEA | ≤5 | 112 | 51.4% |
| Â | >5 | 106 | 48.6% |
CA19-9 | ≤30 | 86 | 39.4% |
| Â | >30 | 132 | 60.6% |
CA 72-4 | ≤7 | 40 | 18.3% |
| Â | >7 | 178 | 81.7% |
| Â | <2.2 | 88 | 40.4% |
DNA Index | 2.2-3.6 | 88 | 40.4% |
| Â | >3.6 | 42 | 19.2% |